Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Warnock

Showing results (81-90 of 209) with videos related to

Pageof 21
Sort By:
Kidney International Reports|January 14, 2026
Impact of Proteinuria on Renal Outcomes in the BALANCE TrialEric L Wallace, Christoph Wanner, Giovanni Piotti, et al.
Nature Reviews. Nephrology|January 15, 2014
Blood pressure and amiloride-sensitive sodium channels in vascular and renal cellsDavid G Warnock, Kristina Kusche-Vihrog, Antoine Tarjus, et al.
Journal of the American Society of Nephrology : JASN|September 13, 2015
Sulfenic Acid Modification of Endothelin B Receptor is Responsible for the Benefit of a Nonsteroidal Mineralocorticoid Receptor Antagonist in Renal IschemiaJonatan Barrera-Chimal, Sonia Prince, Fouad Fadel, et al.
American Journal of Physiology. Renal Physiology|March 6, 2009
The A563T variation of the renal epithelial calcium channel TRPV5 among African Americans enhances calcium influxTao Na, Wei Zhang, Yi Jiang, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 4, 2003
Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administrationVaughn W Folkert, Beckie Michael, Rajiv Agarwal, et al.
Molecular Genetics and Metabolism Reports|July 5, 2022
Understanding and modifying Fabry disease: Rationale and design of a pivotal Phase 3 study and results from a patient-reported outcome validation studyChristoph Wanner, Virginia Kimonis, Juan Politei, et al.
Nephron|December 23, 2014
Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuriaCamilla Tøndel, Takahiro Kanai, Kristin Kampevold Larsen, et al.
Hypertension (Dallas, Tex. : 1979)|July 2, 2003
Angiotensin I conversion to angiotensin II stimulates cortical collecting duct sodium transportPeter Komlosi, Amanda L Fuson, Attila Fintha, et al.
The American Journal of Clinical Nutrition|August 13, 2010
Associations of dietary fat with albuminuria and kidney dysfunctionJulie Lin, Suzanne Judd, Anh Le, et al.
Springerplus|May 15, 2014
Association of inflammatory and endothelial cell activation biomarkers with acute kidney injury after sepsisT Clark Powell, Stephen L Powell, Bryant K Allen, et al.
Pageof 21

Showing results (81-90 of 209) with videos related to

Sort By:
Pageof 21
Kidney International Reports|January 14, 2026
Impact of Proteinuria on Renal Outcomes in the BALANCE TrialEric L Wallace, Christoph Wanner, Giovanni Piotti, et al.
Nature Reviews. Nephrology|January 15, 2014
Blood pressure and amiloride-sensitive sodium channels in vascular and renal cellsDavid G Warnock, Kristina Kusche-Vihrog, Antoine Tarjus, et al.
Journal of the American Society of Nephrology : JASN|September 13, 2015
Sulfenic Acid Modification of Endothelin B Receptor is Responsible for the Benefit of a Nonsteroidal Mineralocorticoid Receptor Antagonist in Renal IschemiaJonatan Barrera-Chimal, Sonia Prince, Fouad Fadel, et al.
American Journal of Physiology. Renal Physiology|March 6, 2009
The A563T variation of the renal epithelial calcium channel TRPV5 among African Americans enhances calcium influxTao Na, Wei Zhang, Yi Jiang, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 4, 2003
Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administrationVaughn W Folkert, Beckie Michael, Rajiv Agarwal, et al.
Molecular Genetics and Metabolism Reports|July 5, 2022
Understanding and modifying Fabry disease: Rationale and design of a pivotal Phase 3 study and results from a patient-reported outcome validation studyChristoph Wanner, Virginia Kimonis, Juan Politei, et al.
Nephron|December 23, 2014
Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuriaCamilla Tøndel, Takahiro Kanai, Kristin Kampevold Larsen, et al.
Hypertension (Dallas, Tex. : 1979)|July 2, 2003
Angiotensin I conversion to angiotensin II stimulates cortical collecting duct sodium transportPeter Komlosi, Amanda L Fuson, Attila Fintha, et al.
The American Journal of Clinical Nutrition|August 13, 2010
Associations of dietary fat with albuminuria and kidney dysfunctionJulie Lin, Suzanne Judd, Anh Le, et al.
Springerplus|May 15, 2014
Association of inflammatory and endothelial cell activation biomarkers with acute kidney injury after sepsisT Clark Powell, Stephen L Powell, Bryant K Allen, et al.
Pageof 21